P385 Development of an AAV-mediated Pentatricopeptide Repeat Protein (PPR) delivery system for treatment of myotonic dystrophy type 1 (DM1)

Autor: Imai, T., Miyai, M., Tamai, T., Ohta, M., Hada, K., Yagi, Y., Nakanishi, O., Mochizuki, H., Nakamori, M.
Zdroj: In Neuromuscular Disorders October 2023 33 Supplement 1:S154-S155
Databáze: ScienceDirect